Peninsula biotech spins out parasite-fighting drugs to biotech legends' startup
A Peninsula biotech company is supplying a set of parasite-fighting preclinical compounds to a startup created by one of the scientists who co-founded the company more than two decades ago.
Kainomyx Inc. — launched by a Stanford University-connected team including scientist Jim Spudich, a winner of the prestigious Lasker Award — is targeting malaria, leishmaniasis and other parasitic diseases. Spudich was one of the founders of Cytokinetics Inc. (NASDAQ: CYTK), which is taking an equity stake…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Biotechnology | Health Management | Malaria | Parasitic Diseases | Parasitology | Pharmaceuticals